Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protagonist Therapeutics (PTGX) Current Taxes: 2024

Historic Current Taxes for Protagonist Therapeutics (PTGX) over the last 1 years, with Dec 2024 value amounting to $2.7 million.

  • Protagonist Therapeutics' Current Taxes fell 43.21% to $1.9 million in Q1 2025 from the same period last year, while for Mar 2025 it was $1.9 million, marking a year-over-year decrease of 43.21%. This contributed to the annual value of $2.7 million for FY2024, which is N/A change from last year.
  • Per Protagonist Therapeutics' latest filing, its Current Taxes stood at $2.7 million for FY2024.
  • In the past 5 years, Protagonist Therapeutics' Current Taxes ranged from a high of $2.7 million in FY2024 and a low of $2.7 million during FY2024.
  • Its 1-year average for Current Taxes is $2.7 million, with a median of $2.7 million in 2024.